Emerging agents and regimens for treatment of relapsed and refractory acute myeloid leukemia-Reference-Cited by-同舟云学术

Emerging agents and regimens for treatment of relapsed and refractory acute myeloid leukemia

Published:2019-07-11 Issue:1-2 Volume:27 Page:1-14
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Cui Longzhen,Liu Yan,Pang Yifan,Qian Tingting,Quan Liang^ORCID,Cheng Zhiheng^ORCID,Dai Yifeng,Ye Xu,Pang Ying,Shi Jinlong,Ke Xiaoyan,Wu Depei,Fu Lin^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/s41417-019-0119-5.pdf

Reference134 articles.

1. Estey E, Döhner H. Acute myeloid leukaemia. Lancet 2006;368:1894–907.

2. Löwenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341:1051–62.

3. Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 2017;129:424–47.

4. Walter RB, Othus M, Burnett AK, Löwenberg B, Kantarjian HM, Ossenkoppele GJ, et al. Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center. Leukemia 2015;29:312–20.

5. Corces-Zimmerman MR, Hong WJ, Weissman IL, Medeiros BC, Majeti R. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc Natl Acad Sci USA. 2014;111:2548–53.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study;Leukemia & Lymphoma;2024-05-07

2. Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing;Frontiers in Oncology;2024-04-22

3. Decitabine combined with low-dose cytarabine, aclarubicin and rhG-CSF regimen may be a potential alternative for relapsed/refractory acute myeloid leukemia: A single-center study;memo - Magazine of European Medical Oncology;2023-11-20

4. Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia;Best Practice & Research Clinical Haematology;2023-06

5. The Molecular Context of Oxidant Stress Response in Cancer Establishes ALDH1A1 as a Critical Target: What This Means for Acute Myeloid Leukemia;International Journal of Molecular Sciences;2023-05-27